Assessing body fat in children made simpler by new equation

 

tape measure 2406650 960 720

First study to evaluate mental health decision units is underway

A major two year study investigating England's mental health decision units (MHDUs) is being spearheaded by researchers at St George's.

The mixed methods study, known as the Decision study, has been funded by the NIHR. Mental Health Decision units have recently emerged in Mental Health NHS trusts, and are an innovative source of support for people undergoing acute mental health crises. Usually situated in or near mental health hospitals, they provide 24 hour facilities for enhanced assessment, intense treatment and onward signposting. They do not have ward status, and are for a short stay only, from a few hours to a maximum of 3 days. A typical unit might offer shared living quarters with access to snacks and drinks, chairs or recliner beds and meeting or treatment rooms.

mentalhealth counselling

Short-term pedometer interventions produce significant health benefits several years later

Research which followed up two 12-week pedometer-based walking trials in adults showed long-term health benefits for the participants four years later.

Participants in the intervention groups in the PACE-UP and PACE-LIFT studies showed significantly fewer cardiovascular events, including heart attacks and strokes, as well as suffering fewer fractures, compared with those in the control groups in the studies.


St George’s team will help bring binx rapid point of care STI testing to patients

A team of scientists at St George’s are supporting the development of a new technology that could revolutionise sexual health treatment times in the UK.

Professor Tariq Sadiq and his team at the university’s Applied Diagnostic Research and Evaluation Unit (ADREU) have announced their support of the binx health io™ platform, with its chlamydia and gonorrhoea combined rapid test. The platform takes just about 30 minutes to give a result comparable to a central lab test, creating a first-of-its-kind ‘test and treat’ care model for these prevalent sexually transmitted infections.


Consortium wins EU grant to develop new leishmaniasis drug

Professor Sanjeev Krishna and colleagues are heading a consortium that has been awarded EUR3.75 million to develop a treatment for one of the world’s most neglected tropical diseases, leishmaniasis.

The funding is for full development of an exciting treatment prospect that has already shown promise in laboratory studies.